Merck (MRK) Return on Capital Employed Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROCE Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
806.00 |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
1,180.00 |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
632.00 |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-1,083.00 |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
486.00 |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
341.00 |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
-467.00 |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
479.00 |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-1,083.00 |
| Dec 31, 2025 |
-87.00 |
| Sep 30, 2025 |
936.00 |
| Jun 30, 2025 |
499.00 |
| Mar 31, 2025 |
2,018.00 |
| Dec 31, 2024 |
2,291.00 |
| Sep 30, 2024 |
866.00 |
| Jun 30, 2024 |
1,226.00 |
| Mar 31, 2024 |
-1,373.00 |
| Dec 31, 2023 |
-1,642.00 |
| Sep 30, 2023 |
-981.00 |
| Jun 30, 2023 |
-1,443.00 |
| Mar 31, 2023 |
-78.00 |
| Dec 31, 2022 |
-149.00 |
| Sep 30, 2022 |
1,009.00 |
| Jun 30, 2022 |
1,568.00 |
| Mar 31, 2022 |
1,242.00 |
| Dec 31, 2021 |
1,195.00 |
| Sep 30, 2021 |
-666.00 |
| Jun 30, 2021 |
-737.00 |
| Mar 31, 2021 |
-540.00 |
| Dec 31, 2020 |
-376.00 |
| Sep 30, 2020 |
-20.00 |
| Jun 30, 2020 |
-360.00 |
| Mar 31, 2020 |
-246.00 |
| Dec 31, 2019 |
-6.00 |
| Sep 30, 2019 |
465.00 |
| Jun 30, 2019 |
883.00 |
| Mar 31, 2019 |
564.00 |
| Dec 31, 2018 |
118.00 |
| Sep 30, 2018 |
472.00 |
| Jun 30, 2018 |
-231.00 |
| Mar 31, 2018 |
86.00 |
| Dec 31, 2017 |
278.00 |
| Sep 30, 2017 |
-401.00 |
| Jun 30, 2017 |
87.00 |
| Mar 31, 2017 |
12.00 |
| Dec 31, 2016 |
-18.00 |
| Sep 30, 2016 |
-1,111.00 |
| Jun 30, 2016 |
-1,040.00 |
| Mar 31, 2016 |
-1,141.00 |
| Dec 31, 2015 |
-1,222.00 |
| Sep 30, 2015 |
1,664.00 |
| Jun 30, 2015 |
1,286.00 |
| Mar 31, 2015 |
1,295.00 |
| Dec 31, 2014 |
1,357.00 |
| Sep 30, 2014 |
-251.00 |
| Jun 30, 2012 |
673.00 |
| Mar 31, 2012 |
621.00 |
| Dec 31, 2011 |
196.00 |
| Sep 30, 2011 |
-445.00 |
| Jun 30, 2011 |
-1,228.00 |
| Mar 31, 2011 |
-1,804.00 |
| Dec 31, 2010 |
-1,689.00 |
| Sep 30, 2010 |
-4,792.00 |
